236 related articles for article (PubMed ID: 18368382)
21. The renin-angiotensin system and experimental heart failure.
Wollert KC; Drexler H
Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
[TBL] [Abstract][Full Text] [Related]
22. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M
Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869
[TBL] [Abstract][Full Text] [Related]
23. Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.
Galandrin S; Denis C; Boularan C; Marie J; M'Kadmi C; Pilette C; Dubroca C; Nicaise Y; Seguelas MH; N'Guyen D; Banères JL; Pathak A; Sénard JM; Galés C
Hypertension; 2016 Dec; 68(6):1365-1374. PubMed ID: 27698068
[TBL] [Abstract][Full Text] [Related]
24. The angiotensin II type 2 receptor in cardiovascular disease.
Lemarié CA; Schiffrin EL
J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):19-31. PubMed ID: 19861349
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.
Mehta PK; Griendling KK
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C82-97. PubMed ID: 16870827
[TBL] [Abstract][Full Text] [Related]
26. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
Oestreicher EM; Martinez-Vasquez D; Stone JR; Jonasson L; Roubsanthisuk W; Mukasa K; Adler GK
Circulation; 2003 Nov; 108(20):2517-23. PubMed ID: 14581407
[TBL] [Abstract][Full Text] [Related]
27. Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction.
Jing F; Mogi M; Horiuchi M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):23-8. PubMed ID: 22465098
[TBL] [Abstract][Full Text] [Related]
28. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
[TBL] [Abstract][Full Text] [Related]
29. Electrophysiological responses of sympathetic preganglionic neurons to ANG II and aldosterone.
Minoura Y; Onimaru H; Iigaya K; Homma I; Kobayashi Y
Am J Physiol Regul Integr Comp Physiol; 2009 Sep; 297(3):R699-706. PubMed ID: 19553504
[TBL] [Abstract][Full Text] [Related]
30. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
Mazak I; Fiebeler A; Muller DN; Park JK; Shagdarsuren E; Lindschau C; Dechend R; Viedt C; Pilz B; Haller H; Luft FC
Circulation; 2004 Jun; 109(22):2792-800. PubMed ID: 15159288
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin III induces p38 Mitogen-activated protein kinase leading to proliferation of vascular smooth muscle cells.
Alanazi AZ; Clark MA
Pharmacol Rep; 2020 Feb; 72(1):246-253. PubMed ID: 32016850
[TBL] [Abstract][Full Text] [Related]
32. Effects of angiotensin II on kinase-mediated sodium and potassium transport in the distal nephron.
van der Lubbe N; Zietse R; Hoorn EJ
Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):120-6. PubMed ID: 23165113
[TBL] [Abstract][Full Text] [Related]
33. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
Zhang WW; Zheng RH; Bai F; Sturdivant K; Wang NP; James EA; Bose HS; Zhao ZQ
Mol Biol Rep; 2020 Feb; 47(2):1207-1222. PubMed ID: 31820314
[TBL] [Abstract][Full Text] [Related]
34. Mineralocorticoid and angiotensin II type 1 receptors in the subfornical organ mediate angiotensin II - induced hypothalamic reactive oxygen species and hypertension.
Wang HW; Huang BS; White RA; Chen A; Ahmad M; Leenen FH
Neuroscience; 2016 Aug; 329():112-21. PubMed ID: 27163380
[TBL] [Abstract][Full Text] [Related]
35. Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways.
Pang HW; Linares A; Couling L; Santollo J; Ancheta L; Daniels D; Speth RC
Endocrine; 2019 Nov; 66(2):349-359. PubMed ID: 31020463
[TBL] [Abstract][Full Text] [Related]
36. Effects of aldosterone on coronary function.
Benard L; Milliez P; Ambroisine ML; Messaoudi S; Samuel JL; Delcayre C
Pharmacol Rep; 2009; 61(1):58-66. PubMed ID: 19307693
[TBL] [Abstract][Full Text] [Related]
37. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
Castro-Chaves P; Leite-Moreira AF
Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
[TBL] [Abstract][Full Text] [Related]
38. New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system.
Nishiyama A; Kim-Mitsuyama S
J Pharmacol Sci; 2010; 113(4):289-91. PubMed ID: 20675960
[TBL] [Abstract][Full Text] [Related]
39. Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion.
Romero DG; Zhou MY; Yanes LL; Plonczynski MW; Washington TR; Gomez-Sanchez CE; Gomez-Sanchez EP
J Endocrinol; 2007 Aug; 194(2):429-40. PubMed ID: 17641290
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
Higuchi S; Ohtsu H; Suzuki H; Shirai H; Frank GD; Eguchi S
Clin Sci (Lond); 2007 Apr; 112(8):417-28. PubMed ID: 17346243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
